GeneDx Holdings Corp.
WGS
$166.95
$1.340.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.08M | 1.41M | -38.58M | -52.29M | -83.50M |
| Total Depreciation and Amortization | 23.00M | 22.46M | 21.48M | 21.05M | 15.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 2.60M |
| Total Other Non-Cash Items | 31.72M | 15.67M | 28.90M | 27.48M | 35.19M |
| Change in Net Operating Assets | -23.62M | -26.50M | -13.71M | -24.75M | -25.35M |
| Cash from Operations | 33.19M | 13.02M | -1.90M | -28.50M | -55.17M |
| Capital Expenditure | -17.72M | -12.19M | -11.18M | -5.49M | -4.82M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 147.00K |
| Cash Acquisitions | -33.20M | -33.20M | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.00K | -8.64M | -29.21M | -24.64M | -29.81M |
| Cash from Investing | -50.96M | -54.03M | -40.38M | -30.13M | -34.48M |
| Total Debt Issued | -- | -- | -- | -- | 48.55M |
| Total Debt Repaid | -4.51M | -4.00M | -3.67M | -3.23M | -3.16M |
| Issuance of Common Stock | 60.36M | 63.05M | 61.99M | 47.39M | 14.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 55.86M | 59.06M | 58.32M | 44.16M | 60.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.08M | 18.05M | 16.03M | -14.47M | -29.41M |